What Is HPLC Testing?

Almost every research peptide listing carries a purity figure, and almost all cite the same method: HPLC. The number is easy to read and easy to compare. It is much harder to interpret, because a purity percentage only means something once you know what the method measured and what it could not see.

What HPLC means

HPLC stands for high-performance liquid chromatography. It is an analytical separation technique, not a single test: a mixture is pushed through a column that separates its components, and a detector records what comes out and when.

The technique underpins pharmacopoeial purity monographs and is the first-line purity method for synthetic peptides in essentially every analytical laboratory.[1] Peptides suit it well: they dissolve readily in the solvent systems involved, they absorb ultraviolet light at low wavelengths, and they behave predictably on the column chemistries in common use.

How separation works

The sample is dissolved and injected into a stream of solvent — the mobile phase — which a pump drives at high pressure through a steel column packed with fine particles. Those particles are the stationary phase.

Peptide analysis almost always uses reversed-phase chromatography. The particles are coated with non-polar hydrocarbon chains, typically eighteen carbons long, and the mobile phase is water and acetonitrile with a little acid added. The proportion of acetonitrile is raised steadily across the run — a gradient.

At the start of the gradient, when the mobile phase is mostly water, hydrophobic molecules cling to the non-polar stationary phase. As acetonitrile increases they release and travel down the column, with more hydrophobic species holding on longer and emerging later. Each component therefore leaves the column at a characteristic time, called its retention time.

A detector sits at the column outlet. For peptides this is usually an ultraviolet detector set around 210 to 220 nanometres, where the peptide bond itself absorbs.[2]

One point is worth holding onto: separation happens by physical behaviour, not chemical identity. The column sorts molecules by how strongly they interact with the stationary phase. It has no concept of what any of them are.

What a chromatogram represents

The detector output is plotted as a chromatogram — retention time along the horizontal axis, detector response along the vertical. The trace runs flat along a baseline and rises into peaks as material passes the detector.

Each peak represents something that absorbed at the detector's wavelength and eluted at that moment. In a well-made sample one large peak dominates — the target compound. Smaller peaks are usually related substances from synthesis or handling: sequences missing a residue, chains that terminated early, incompletely deprotected material, oxidised variants, or dimers.

The area enclosed by a peak is proportional to how much UV-absorbing material passed the detector. Height is a cruder indicator, since peaks broaden as retention time increases. Area is what gets integrated, and area is what purity calculations are built on.

How relative purity is reported

The standard calculation is area normalisation. The software integrates every peak in the chromatogram, sums those areas, and expresses the main peak as a percentage of that total.[1],[2]

So a result of "≥99% by HPLC" means the main peak accounted for at least ninety-nine per cent of the total integrated peak area, under the specific conditions of that method.

Two qualifiers in that sentence carry real weight. The figure is relative — a share of what the detector registered, not a share of everything in the vial. And it is tied to that method — a different column, gradient, or wavelength can produce a different number from the same material.

What HPLC does not establish by itself

The method is genuinely powerful within its scope. The scope is narrower than the headline percentage suggests.

It does not confirm identity. Retention time is characteristic of a compound under fixed conditions but not unique to it — another molecule of comparable hydrophobicity can elute at a similar time. HPLC alone cannot tell you the main peak is the compound named on the label.

It only sees what the detector sees. Response at 214 nm is not uniform across species. The peptide bond has a molar extinction coefficient of roughly 923 M⁻¹cm⁻¹ at that wavelength, while tryptophan absorbs around thirty times more strongly.[3] Species lacking a suitable chromophore altogether — inorganic salts, residual water, counterions carried over from purification, some solvents — contribute little or nothing to the total area. Such material can make up a meaningful share of the vial's mass while barely registering in the chromatogram. This is the single most common source of confusion around peptide purity figures.

It says nothing about quantity. A sample can be 99% pure and still contain less peptide than its label states. Purity and content are separate measurements answering separate questions.

Peaks can overlap. If an impurity happens to elute at the same time as the main compound, its area is counted inside the main peak and inflates the result. Method design — column chemistry, gradient slope, run length — determines how well the method resolves closely related substances, which is why regulatory guidance on method validation asks specifically for demonstrated resolution between the two components that elute closest together.[4]

It is not a safety or sterility test. Microbial content, endotoxin, and sterility are assessed by entirely different procedures. A chromatogram addresses none of them.

Why HPLC is paired with identity analysis

The usual companion technique is mass spectrometry. The sample is ionised and the instrument measures the mass-to-charge ratio of the resulting ions, giving an observed molecular mass. That value is compared against the mass calculated from the compound's known sequence. A match within the method's tolerance is evidence that the material is the expected molecule. Regulatory guidance treats identity and purity as distinct specification attributes for exactly this reason.[5] The two techniques are frequently coupled in a single instrument, with the chromatograph feeding directly into the mass spectrometer.

Together they answer complementary questions. HPLC establishes how much of the detected material was the main component; mass spectrometry establishes whether that component is the compound it is supposed to be. A purity figure without an identity confirmation leaves the more fundamental question open. How peptide purity is measured covers that pairing, and the separate question of quantity, in more detail.

Seeing this in practice

Our Quality Control page sets out the testing applied to Peptiva material and the standard applied at release. The reports we hold are published on the Test Results page, so the figures can be examined rather than taken on trust.

All products supplied by Peptiva are intended strictly for in vitro research and laboratory use. They are not for human or animal consumption, nor for diagnostic, therapeutic, or medicinal purposes. This article is provided as general analytical background and is not laboratory, medical, or regulatory advice.